<!DOCTYPE html>
<html>
<head>
<title>EP Trials Review 2020: Trend in AF Mortality</title>
<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-119340815-7"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-119340815-7');
</script>

</head>

<meta name="viewport" content="width=device-width, initial-scale=1">
<link rel="icon" href="box transparent.png" type="image/png" sizes="60x60">
<link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
<link href="https://fonts.googleapis.com/css2?family=Eczar&family=Rubik&display=swap" rel="stylesheet">
<script src="https://kit.fontawesome.com/2c3e1e841c.js" crossorigin="anonymous"></script>

<style>
/*fonts*/
.sans {font-family: 'Rubik', sans-serif;}
.serif {font-family: 'Eczar', serif;}

.headLine {
    font-family: 'Eczar', serif;font-size: 2.8vmax;line-height: 120%;
}
.pGraph {
    font-family: 'Rubik', sans-serif;font-size: 1.7vmax;line-height: 120%; 
    color: #555555;text-indent: 4vmax;padding-top: 2vmax;text-align: justify;
}
.figure {padding:1.5vmax;width: 100%;border: #ddd solid 0.1vmin;margin-top: 2vmax;}
.caption {font-family: 'Eczar', serif;font-size: 1.5vmax;line-height: 120%;color: #a8a8a8;padding-bottom: 2vmax;}
.ref {font-size: 0.9vmax;color: #777777;font-family: 'Rubik', sans-serif;
line-height: 120%;margin-top: 0.5vh}

</style>

<body>
<!--main title-->
 
<div class="w3-center" style="line-height: 200%;width: 100%;padding: 3vmax 0;">
    <div>
        <a href="https://heartrhythmbox.com" target="_blank">
            <img src="box transparent.png" style="width: 4vmax;padding-bottom: 1.5vmax;"></a>
    </div>
    <div class="serif" style="font-size: 5vmax;padding: 1vmax;">
        EP Trials Review
    </div>
    <div class="sans" style="font-size: 1.5vmax;color: #555555;background-color: #eeeeee;">
        Trends in AF Mortality
    </div>
</div> 

<!--content-->
<div style="width:auto;max-width: 800px;margin-left: auto;margin-right: auto;
padding:2vmax">
        <div class="headLine">
            Less life-year loss in AF patients over the last decade.
        </div>
        <div class="ref">
            Ref:
            <a href="https://doi.org/10.1136/bmj.m2724" target="_blank">
            Trends in excess mortality associated with AF. BMJ 2020.</a></div>
        <div class="pGraph">
            In the Framingham Heart Study, the mean number of life years lost to AF at 10 years improved 
            significantly over the past 45 years, but <b>a 2-year gap</b> compared with individuals without AF was still present. 
        </div>
        <img src="media/Framingham/mortalityTrends.jpg" class="figure">
        <div class="caption">
            Temporal trends for the association between newly diagnosed atrial fibrillation and all cause mortality.
        </div>
        <div class="pGraph">
            Newly diagnosed atrial fibrillation was associated with an increased hazard of 
            death over three time periods; 1972-1985, 1986-2000, and 2001-2015. In the model 
            adjusted for time varying covariates, there was no evidence of a temporal trend in hazard ratios (P<sub>trend</sub>=0.70). 
        </div>
        <div style="border-bottom:double 0.3vmax #797979;height: 2vh;padding: 2vmax;">
        </div> 
        <img src="media/Framingham/survivalCurves.jpg" class="figure">
        <div class="caption">
            Adjusted survival curves for participants with atrial fibrillation and matched referents.
        </div>
        <div class="pGraph" style="padding-bottom: 3vmax;">
            To assess the loss in lifetime over 10 years after a diagnosis of AF, 
            the authors analyzed 305 participants with AF and 610 matched referents in time 
            period 1, 589 participants and 1170 referents in period 2, and 453 participants 
            and 892 referents in period 3. The adjusted difference in the restricted mean 
            survival time at 10 years between participants with AF and referents was 
            −2.85 years (95%CI −3.21 to −2.50) in time period 1 (1972-1985), 
            −2.10 years (95%CI −2.35 to −1.84) in period 2 (1986-2000), and −1.99 years (95% CI −2.26 to −1.72) in period 3 (P<sub>trend</sub>=0.03).
        </div>
   
    <!--home/top-->
    <div class="sans w3-center">
    <a href="index.html" target="_blank">
        <i class="fas fa-home" 
        style="font-size: 2.5vmax;color:#a8a8a8;"></i></a>
    &nbsp;&nbsp;
    <a href="#top"><i class="fas fa-arrow-circle-up" style="font-size: 2.5vmax;color: #a8a8a8;"></i>
    </a>
    </div>

</div>



<!--end page-->
<div class="w3-container sans w3-center" 
style="margin-top:10vh;background:#f1f1f1;font-size: 1vmax;padding: 2vmax;color:#797979">
    <img src="box transparent.png" style="width: 2vmax;">
    <br>
    HeartRhythmBox, an education page of heart rhythm topics.<br>
    visit us at <a href="https://heartrhythmbox.com" target="_blank">
    www.heartrhythmbox.com</a><br>
    or <a href="https://www.facebook.com/HeartRhythmBox/" target="_blank">https://www.facebook.com/HeartRhythmBox/</a>
</div>


</body>

</html>